Progyny, Inc. (PGNY)
| Market Cap | 5.01B |
| Revenue (ttm) | 450.01M |
| Net Income (ttm) | 78.11M |
| Shares Out | 88.17M |
| EPS (ttm) | 0.78 |
| PE Ratio | 71.87 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 736,010 |
| Open | 59.25 |
| Previous Close | 58.29 |
| Day's Range | 55.78 - 59.25 |
| 52-Week Range | 23.56 - 66.61 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 70.20 (+25.4%) |
| Est. Earnings Date | Nov 4, 2021 |
About PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimburseme...
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for Progyny stock is "Strong Buy." The 12-month stock price forecast is 70.20, which is an increase of 25.38% from the latest price.
News
3 Innovative Growth Stocks That'll Make You Richer Through 2025
Their products are better than those of their rivals, and their leads are increasing.
Despite A 25% Rise In A Month Progyny Stock May Continue To See Higher Levels
The stock price of Progyny (NASDAQ: PGNY), a benefits management company that specializes in fertility and family building benefits solutions, has seen a rise of around 25% over the last month (twenty-o...
Progyny, Inc. to Present at the BofA Global Healthcare Conference
NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, to...
Why This Ultra-High-Growth Healthcare Stock Is a Buy
When a founder-led company is profitably chasing a huge market and having early success, the stock is worth a closer look.
5 Medical Services Stocks Countering Industry Headwinds
The Zacks Medical - Services industry is growing on digital healthcare adoption. HQY, PGNY, SGRY, MODV, and AGTI are set to gain the most.
Progyny, Inc. to Present at the BofA Securities SMID Cap 2H21 Ideas Conference
NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, tod...
Progyny's Stock Is Getting Hammered On Mixed Q2 Earnings; Outlook Lagging Street Consensus
Progyny Inc (NASDAQ: PGNY) reported Q2 EPS of $0.19, a turnaround from EPS loss of $(0.01) a year ago, edging out analysts' average expectation of $0.08. Sales almost doubled to $128.6 million but misse...
Progyny (PGNY) Beats Q2 Earnings Estimates
Progyny (PGNY) delivered earnings and revenue surprises of 111.11% and -0.24%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Progyny: Q2 Earnings Insights
Shares of Progyny (NASDAQ:PGNY) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 1050.00% over the past year to $0.19, which beat the es...
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth
Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Progyny, Inc. Announces Details for Its Second Quarter 2021 Results Report
NEW YORK, July 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, wil...
Progyny (PGNY) Moves to Strong Buy: Rationale Behind the Upgrade
Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
4 Stocks With High Net Income Ratio to Scoop Up
APPS, QFIN, PGNY, and SSP have qualified the screen for high net income ratio stocks.
Progyny (PGNY) Sees Hammer Chart Pattern: Time to Buy?
Progyny (PGNY) has been struggling lately, but the selling pressure may be coming to an end soon.
I'm selling Progyny this week [June 24th], and this is why!
Progyny, Inc (NASDAQ: PGNY) shares have advanced more than 40% since the beginning of January 2021, and the current share price stands around $59. Progyny expects adjusted EBITDA between $70 million to...
Here's Why Progyny (PGNY) is a Great Momentum Stock to Buy
Does Progyny (PGNY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Progyny's (PGNY) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Progyny, Inc. (PGNY)
Progyny, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, tod...
Earnings Estimates Moving Higher for Progyny (PGNY): Time to Buy?
Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's What Could Help Progyny (PGNY) Maintain Its Recent Price Strength
Progyny (PGNY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "R...
Largest Research Study on Decision Making of Single or Coupled Intended Fathers Selected for Presentation at 2021 ACO...
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, alon...
Welltok Welcomes Maven and Progyny to its Connect Ecosystem Family
DENVER, May 19, 2021 /PRNewswire/ -- Family planning and fertility benefits are becoming more mainstream with employers seeking to demonstrate inclusivity and attract or retain talent. As women become m...
Progyny, Inc. to Present at the BofA Securities 2021 Health Care Conference
NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, toda...
Progyny (PGNY) Q1 Earnings and Revenues Surpass Estimates
Progyny (PGNY) delivered earnings and revenue surprises of 87.50% and 0.46%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?